Raghav, K. P. S., Hubert, A., Fakih, M., Fang, H., Aristide, M. R. N., Almeida, C. B. D., Vasilopoulos, A., Sui, Y., Strickler, J. H. (2025). Phase 2 randomized study evaluating safety, efficacy, and optimal dose of ABBV-400 in combination with fluorouracil, folinic acid, and bevacizumab in previously treated patients with metastatic colorectal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps308